...
首页> 外文期刊>Organometallics >2-methylimidazol-1-yl-substituted analogs of hexahydro-difenidol (HHD) and hexahydro-sila-difenidol (HHSiD) as M-3 receptor-preferring muscarinic antagonists: A study on C/Si bioisosterism
【24h】

2-methylimidazol-1-yl-substituted analogs of hexahydro-difenidol (HHD) and hexahydro-sila-difenidol (HHSiD) as M-3 receptor-preferring muscarinic antagonists: A study on C/Si bioisosterism

机译:作为M-3受体首选毒蕈碱拮抗剂的六氢-二苯甲腈(HHD)和六氢-二氢二苯甲腈(HHSiD)的2-甲基咪唑-1-基取代的类似物:C / Si生物等位基因研究

获取原文
获取原文并翻译 | 示例
           

摘要

The hexahydro-sila-difenidol (HHSiD, 1b) and p-fluoro-hexahydro-sila-difenidoI (p-F-HHSiD, 2b) derivatives cyclohexyl[3-(2-methylimidazol-1-yl)propyl]phenylsilanol (4b) and cyclohexyl(4-fluorophenyl)[3-(2-methylimidazol-1-yl)propyl]silanol (5b) were synthesized in three-step syntheses, starting from (3-chloropropyl)cyclohexyldimethoxysilane. In addition, the corresponding carbon analogs 4a and 5a (--> Si/C replacement) were prepared in two-step syntheses, starting from 2-(3-chloropropyl)-2-phenyl-1,3-dioxolane and 2-(3-chloropropyl)2-(4-fluorophenyl)-1,3-dioxolane, respectively. The C/Si pairs 4a/4b and 5a/5b were studied for their affinities at recombinant human muscarinic M-1, M-2, M-3, M-4, and M-5 receptors stably expressed in CHO-K1 cells by evaluating their ability to inhibit the binding of the muscarinic antagonist [H-3]N-methylscopolamine. These studies revealed that compounds 4a, 4b, 5a, and 5b behave as simple competitive antagonists at M-1-M-5 receptors. The exchange of the piperidin-1-yl group of the parent compounds HHD (1a), HHSiD (1b), p-F-HHD (2a), and p-F-HHSiD (2b) by a 2-methylimidazol-1-yl moiety resulted in a novel, potent, and M-3-preferring antimuscarinic agent, compound 4b. The affinities of compounds 4a, 5a, and 5b for muscarinic M-1 (pK(i) = 7.74-7.93), M-2 (PKi = 7.03-7.14), M-3 (pK(i) = 8.04-8.11), M4 (pK(i) = 7.63-7.94), and M-5 receptors (pK(i) = 7.29-7.52) were very similar at the individual receptor subtypes and in turn very similar to those of the parent compounds 1a, 2a, and 2b. In contrast, replacement of the piperidin-1-yl substituent of 1b by a 2-methylimidazol-1-yl group (--> 4b) increased the affinity for M-1-M-5 receptors up to 8.3-fold. The muscarinic receptor affinity profile of 4b was found to be M-3 (pK(i) = 8.69) > M-1 (pK(i) = 8.39) M-4 (pK(i) = 8.32) > M-5 (pK(i) = 8.02) > M-2 (pK(i) = 7.43). Thus, compound 4b displayed a M-3 versus M-2 receptor selectivity (18.2-fold). The receptor subtype affinities of the carbon compound 5a were very similar to those of the corresponding silicon analog 5b, whereas sila-substitution of 4a (- 4b) increased the affinities for M-1-M-5 receptors, this increase being greatest at M-3 and M-5 receptors (4-fold). [References: 27]
机译:六氢硅拉二苯二酚(HHSiD,1b)和对氟六氢硅拉二芬尼多(pF-HHSiD,2b)衍生物环己基[3-(2-甲基咪唑-1-基)丙基]苯基硅烷醇(4b)和环己基从(3-氯丙基)环己基二甲氧基硅烷开始,以三步合成法合成了(4-氟苯基)[3-(2-甲基咪唑-1-基)丙基]硅烷醇(5b)。此外,分两步合成制备了相应的碳类似物4a和5a(-> Si / C取代),从2-(3-氯丙基)-2-苯基-1,3-二氧戊环和2-( 3-氯丙基)2-(4-氟苯基)-1,3-二氧戊环。研究了C / Si对4a / 4b和5a / 5b与CHO-K1细胞中稳定表达的重组人毒蕈碱M-1,M-2,M-3,M-4和M-5受体的亲和力。评估它们抑制毒蕈碱拮抗剂[H-3] N-甲基东pol碱结合的能力。这些研究表明,化合物4a,4b,5a和5b充当M-1-M-5受体的简单竞争性拮抗剂。母体化合物HHD(1a),HHSiD(1b),pF-HHD(2a)和pF-HHSiD(2b)的哌啶-1-基被2-甲基咪唑-1-基取代一种新型,有效且M-3首选的抗毒蕈碱剂化合物4b。化合物4a,5a和5b对毒蕈碱M-1(pK(i)= 7.74-7.93),M-2(PKi = 7.03-7.14),M-3(pK(i)= 8.04-8.11)的亲和力,M4(pK(i)= 7.63-7.94)和M-5受体(pK(i)= 7.29-7.52)在各个受体亚型上非常相似,进而与母体化合物1a,2a非常相似和2b。相反,用2-甲基咪唑-1-基(-> 4b)取代1b的哌啶-1-基取代基(-> 4b)将对M-1-M-5受体的亲和力提高到8.3倍。发现4b的毒蕈碱受体亲和力分布为M-3(pK(i)= 8.69)> M-1(pK(i)= 8.39)M-4(pK(i)= 8.32)> M-5( pK(i)= 8.02)> M-2(pK(i)= 7.43)。因此,化合物4b显示出M-3对M-2受体的选择性(18.2倍)。碳化合物5a的受体亚型亲和力与相应的硅类似物5b的亲和力非常相似,而4a(-4b)的sila取代增加了M-1-M-5受体的亲和力,这种增加在M处最大-3和M-5受体(4倍)。 [参考:27]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号